Pretomanid, a novel compound developed by the non-profit organisation, TB Alliance, has been granted a conditional marketing authorisation by the European Commission (EC) for...
Nigeria has received $890 million grant from Global Fund to reduce the burden of HIV, Tuberculosis and Malaria over an implementation period of three...
A new report says that the global response to the COVID-19 pandemic is having unintended yet drastic consequences on tuberculosis (TB) services, with lockdowns...
TB Alliance and the broader TB community are asking the World Health Organisation (WHO) to add Mycobacterium tuberculosis to the critical group within the list of drug-resistant...
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
The Global Alliance for TB Drug Development (TB Alliance) has...
